Profil bibliographique

Eric Van Cutsem

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

3Publications signalées

0Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Cancer Immunotherapy and BiomarkersColorectal Cancer Treatments and StudiesGenetic factors in colorectal cancerEsophageal Cancer Research and TreatmentGastric Cancer Management and Outcomes

Publications récentes

2026 conference-abstract

Nivolumab + ipilimumab (NIVO + IPI) vs NIVO in microsatellite instability high/mismatch repair-deficient metastatic colorectal cancer (MSI-H/dMMR mCRC): CheckMate 8HW subgroup analyses including treatment-free status and outcomes in long-term survivors.

E Elez, Thierry Andre, Sara Lonardi, Heinz-Josef Lenz et autres

0 citationsJournal of Clinical Oncology

2026 conference-abstract

Efficacy of durvalumab and safety by treatment period in MATTERHORN: A randomized, phase 3 study of durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) chemotherapy in resectable gastric/gastroesophageal junction (G/GEJ) cancer.

Zev A. Wainberg, Eric Van Cutsem, Thorsten Götze, Mehmet Ali Nahit Sendur et autres

0 citationsJournal of Clinical Oncology

2026 conference-abstract

Association of progression-free survival (PFS) with microsatellite instability–high (MSI-H) or mismatch repair–deficient (dMMR) status determined by single vs dual validated companion diagnostic (CDx) assays: CheckMate-8HW post hoc analyses.

Thierry Andre, Sara Lonardi, E Elez, Eric Van Cutsem et autres

0 citationsJournal of Clinical Oncology

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.